# How to Choose the Right Treatment for Peyronie's Disease
Peyronie's disease affects roughly 1 in 100 men, causing penile curvature that can interfere with sexual function and psychological wellbeing. Treatment options range from oral medications to surgical interventions, and selecting the right approach depends on disease severity, duration, and individual patient factors.
Peyronie's disease develops when scar tissue forms inside the penis, typically following trauma during sexual activity or microvascular injury. The condition progresses through two phases: an acute inflammatory phase lasting 12 to 18 months, where curvature worsens and pain occurs, and a stabilization phase where symptoms plateau. Treatment timing matters. Early intervention during the active phase offers better outcomes than waiting for stabilization.
Medications represent the first-line approach for most men. Collagenase clostridium histolyticum (Xiaflex) received FDA approval and works by breaking down excess collagen deposits in scar tissue. Studies show it reduces curvature by an average of 34 percent when combined with penile traction therapy. Verapamil, a calcium channel blocker, appears in topical and injection forms. Research indicates intralesional verapamil injection reduces pain and may slow curvature progression, particularly in early disease. Pentoxifylline, an oral medication that improves blood flow, shows modest benefits in some trials.
Penile traction therapy complements pharmaceutical treatment. The approach uses mechanical devices to stretch scar tissue over several months. Clinical evidence supports its use alongside medications, with some studies reporting curvature reduction of 20 to 30 percent when patients maintain consistent use for six to nine hours daily.
Surgical options become relevant when medical therapy fails or curvature severely restricts sexual function. Plication procedures involve shortening the side of the penis opposite the curve, effectively straightening the organ without removing tissue. This outpatient surgery carries minimal erectile dysfunction risk and shows high patient satisfaction rates. Corporal grafting replaces scar tissue with tissue grafts, preserving penile length but carrying higher complication rates including infection and erectile dysfunction.
Penile implants address concurrent erectile dysfunction while treating curvature. Malleable implants provide simplicity but less natural appearance, while inflatable devices offer improved cosmetics and function. Implant surgery represents definitive treatment for men with both Peyronie's disease and ED, with satisfaction rates exceeding 85 percent in most studies.
Psychological factors deserve equal attention. Many men experience depression and anxiety related to sexual dysfunction and body image concerns. Referral to a sex therapist or counselor alongside medical treatment improves outcomes and relationship satisfaction.
The conversation with your urologist should address several specifics: disease duration and progression rate, current erectile function, curvature severity and impact on intercourse, personal health history, and treatment goals. A structured consultation helps distinguish between men needing conservative management and those benefiting from aggressive intervention.
Men with stable disease lasting over 18 months and mild to moderate curvature typically start with observation plus oral medications. More severe acute-phase disease or significant functional impairment warrants combination therapy with medications plus traction devices or earlier surgical consideration. Individual response to treatment varies, necessitating personalized plans rather than one-size-fits-all protocols.